Discovery of a novel Aurora B inhibitor GSK650394 with potent anticancer and anti- aspergillus fumigatus dual efficacies in vitro
Authors:
Open Access
- 11 December 2021
- journal article
- research article
- Published by Taylor & Francis in Journal of Enzyme Inhibition and Medicinal Chemistry
- Vol. 37 (1) , 109-117
Abstract
Invasive fungal infections including Candidiasis and Aspergillosis are associated with considerable morbidity and mortality in immunocompromised individuals, such as cancer patients. Aurora B is a key mitotic kinase required for the cell division of eukaryotes from fungus to man. Here, we identified a novel Aurora B inhibitor GSK650394 that can inhibit the recombinant Aurora B from human and Aspergillus fumigatus, with IC50 values of 5.68 and 1.29 µM, respectively. In HeLa and HepG2 cells, GSK650394 diminishes the endogenous Aurora B activity and causes cell cycle arrest in G2/M phase. Further cell-based assays demonstrate that GSK650394 efficiently suppresses the proliferation of both cancer cells and Aspergillus fumigatus. Finally, the molecular docking calculation and site-directed mutagenesis analyses reveal the molecular mechanism of Aurora B inhibition by GSK650394. Our work is expected to provide new insight into the combinational therapy of cancer and Aspergillus fumigatus infection.Keywords
Funding Information
- National Natural Science Foundation of China (31971222)
This publication has 43 references indexed in Scilit:
- Emergence of Azole-Resistant Aspergillus fumigatus Strains due to Agricultural Azole Use Creates an Increasing Threat to Human HealthPLOS Pathogens, 2013
- Phase I Study Assessing the Safety and Tolerability of Barasertib (AZD1152) With Low-Dose Cytosine Arabinoside in Elderly Patients With AMLClinical Lymphoma Myeloma and Leukemia, 2013
- Crystal Structure of Human Aurora B in Complex with INCENP and VX-680Journal of Medicinal Chemistry, 2012
- Aurora kinase inhibitorsCritical Reviews in Oncology/Hematology, 2010
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibilityJournal of Computational Chemistry, 2009
- Development of a Small-Molecule Serum- and Glucocorticoid-Regulated Kinase-1 Antagonist and Its Evaluation as a Prostate Cancer TherapeuticCancer Research, 2008
- Aurora kinase B is a predictive factor for the aggressive recurrence of hepatocellular carcinoma after curative hepatectomyBritish Journal of Surgery, 2008
- The selective Aurora B kinase inhibitor AZD1152 is a potential new treatment for multiple myelomaBritish Journal of Haematology, 2007
- The chromosomal passenger complex: guiding Aurora-B through mitosisJournal of Cell Biology, 2006
- General atomic and molecular electronic structure systemJournal of Computational Chemistry, 1993